{{vm.title}}
25{{vm.includesText}}
{{item}}
{{vm.selectText}}
{{ vm.welcomeLabel.trim() }},
{{ vm.userName }}
{{ vm.text }}
{{vm.newUser1}} {{vm.newUser2}} {{vm.newUser3}} {{vm.newUser4}}
{{ vm.unknownUser }}
{{ vm.title }}
{{ vm.title }}
{{ vm.title }}
- {{ vm.siteSelectorList.flyout.cell1.heading }} {{ site.countryLocale }} {{ vm.siteSelectorList.flyout.cell1.global.countryLocale }}
{{ vm.closeTabLabel }}
- {{ vm.flyout.cell2.title }} {{ vm.flyout.cell2.newTabAllow }} {{ vm.flyout.cell2.title }}
- {{ vm.flyout.cell3.title }} {{ vm.flyout.cell3.newTabAllow }} {{ vm.flyout.cell3.title }}
- {{ vm.flyout.cell1.viewAll.label }} {{ vm.flyout.cell1.viewAll.newTabAllow }} {{ vm.flyout.cell1.viewAll.label }}
The rapid outbreak of the coronavirus presents an alarming health crisis that the world is grappling with. In addition to the human impact, there is also a significant commercial impact being felt globally. As viruses know no borders, the impacts will continue to spread. In fact, 94 percent of the Fortune 1000 are already seeing COVID-19 disruptions.1
It’s possible that the coronavirus threat will eventually fade, as the Ebola, Zika, and Severe Acute Respiratory Syndrome (SARS) viruses have in recent years. But even if it does, the next devastating, yet-unnamed outbreak is not so much a matter of “if” but “when.”
The steps below can help you understand your exposure to COVID-19, and more importantly, position your business to be resilient in the face of this and the next global threat.
Footnote 1: Fortune: Coronavirus Supply Chain Impact, Feb. 21, 2020
Timely insights
Further insights
By Constance L Hunter, Chief Economist, KPMG in the US
Mapping & analyzing the possible impact of COVID-19
By Hilary Thomas, Chief Medical Advisor, KPMG in the UK
Maintaining resilient healthcare systems in the face of COVID-19
By Sophie Heading, Global Geopolitics Lead, Global Clients and Markets
Managing disruption in different scenarios.
By Richard Threlfall, Global Head of Infrastructure
Mapping & analyzing the possible impact of COVID-19.
